Skip to main content
Premium Trial:

Request an Annual Quote

MDS' Q4 Revenues Rise 22 Percent

NEW YORK (GenomeWeb News) – MDS today reported fourth-quarter revenue of $338 million, a 22 percent increase over revenue of $260 million in the comparable quarter a year ago.
MDS Analytical Technologies, which includes the operations of Molecular Devices and Sciex, had revenue growth of 92 percent in the quarter to $119 million. Sciex contributed $65 million to that total, while Molecular Devices brought in revenue of $54 million.
MDS acquired Molecular Devices in March.  
MDS Pharma Services had 1 percent revenue growth year over year to $123 million, while MDS Nordion had revenue of $76 million, flat with last year.
The firm’s R&D costs in the quarter increased 14 percent to $8 million.
MDS posted a profit of $15 million, down from $47 million year over year. But last year’s fourth-quarter results included $33 million in income from discontinued operations.
For full-year 2007, MDS reported revenue of $1.2 billion compared with $1 billion last year. Its net income was $772 million compared with $127 million last year. This year’s results includes $806 million in income from discontinued operations related to the sale of the firm’s Canadian diagnostics business.
As of Oct. 31, MDS had $259 million in cash and cash equivalents.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.